Chen G G, Li M Y, Ho R L K, Chak E C W, Lau W Y, Lai P B S
Department of Surgery, The Chinese University of Hong Kong, Prince of Wales Hospital, Room 306 Cancer Center, Shatin, New Territories, Hong Kong.
J Clin Virol. 2005 Sep;34(1):7-12. doi: 10.1016/j.jcv.2005.01.006.
Chronic infection by hepatitis B virus (HBV) is the leading cause of hepatocellular carcinoma (HCC) in man. The viral transactivator HBV X (HBx) gene plays a critical role in the molecular pathogenesis of HBV-related HCC.
The aim of this study was to investigate whether there were particular HBx mutations associated with the Chinese Hong Kong patients with HCC.
We have examined HBx in 113 tumor tissue samples from patients with HCC and 48 serum samples from the same group. In addition, we also examined the expression of HBx protein and the index of apoptotic cell death in tumor tissues of HCC. The entire coding region of HBx gene from the sample was sequenced and aligned with the published HBx gene sequence.
We have identified total 54 different types of mutations in HBx gene. HBx mutations occurred in a very high percentage of samples tested. Mutation of HBx was found in 95.2% and 95.3% of the tumor tissue and serum samples, respectively. Most of samples contained more than one type of the mutation. Relative risk analysis indicated that the mutations in 12 sites of tissue HBx and nine sites of serum HBx were highly associated with HCC, suggesting a potential role of these mutants in carcinogenesis. An insert mutation at position 204: Insert 204AGGCCC, was always found to co-exist with point mutations at 260 (G-->A) and 264 (G/C/T-->A). Furthermore, this particular pattern of HBx mutation was most frequently detected. Immunochemical staining of HBx protein revealed that the nuclear localization of HBx protein in hepatocytes of tumor tissues was highly associated with this particular pattern of HBx mutation. In conclusion, HBx mutation occurs frequently in HCC samples tested and a sample usually has multiple types of mutations. A special pattern of insert at 204 and point mutations at 260 and 264 was identified, and it appears to be associated with the nuclear localization of HBx protein. The development of multiple types of mutations in a given sample may contribute to the process of multiple steps in hepatocarcinogenesis.
乙型肝炎病毒(HBV)慢性感染是人类肝细胞癌(HCC)的主要病因。病毒反式激活因子HBV X(HBx)基因在HBV相关HCC的分子发病机制中起关键作用。
本研究旨在调查是否存在与中国香港HCC患者相关的特定HBx突变。
我们检测了113例HCC患者的肿瘤组织样本和同一组48份血清样本中的HBx。此外,我们还检测了HCC肿瘤组织中HBx蛋白的表达及凋亡细胞死亡指数。对样本中HBx基因的整个编码区进行测序,并与已发表的HBx基因序列进行比对。
我们在HBx基因中总共鉴定出54种不同类型的突变。HBx突变在检测的样本中出现的比例非常高。在肿瘤组织和血清样本中,分别有95.2%和95.3%发现了HBx突变。大多数样本包含不止一种类型的突变。相对风险分析表明,组织HBx的12个位点和血清HBx的9个位点的突变与HCC高度相关,提示这些突变体在致癌过程中可能发挥作用。204位的插入突变:插入204AGGCCC,总是与260位(G→A)和264位(G/C/T→A)的点突变同时存在。此外,这种特定的HBx突变模式检测频率最高。HBx蛋白的免疫化学染色显示,肿瘤组织肝细胞中HBx蛋白的核定位与这种特定的HBx突变模式高度相关。总之,在检测的HCC样本中HBx突变频繁发生,且一个样本通常有多种类型的突变。鉴定出了204位的特殊插入模式以及260位和264位的点突变,并且似乎与HBx蛋白的核定位有关。给定样本中多种类型突变的发生可能有助于肝癌发生的多步骤进程。